| http://www.w3.org/ns/prov#value | - We believe that the evolving knowledge and therapeutic focus on the EGFR and other pathways will lead to the development of novel targeted agents with increased capacity to reverse the oncogenic process of solid tumors.Nabil F. SabaSue S. YomMissak HaigentzBassel El-Rayes
|
